AMG510 (sotorasib) Plus Lenvatinib As Second-line Treatment in Patients with KRASG12C Mutant, Metastatic NSCLC
Clinical trial NCT06068153 · WITHDRAWN
Trial details
- NCT number
- NCT06068153
- Sponsor
- ETOP IBCSG Partners Foundation
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-01
- Primary completion
- 2026-09-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.